HCC is difficult to diagnose in its early stages; only three widely used biomarkers exist at present: α-fetoprotein (AFP), core fucosylated AFP (AFP-L3), and des-gamma-carboxy prothrombin. The gene discussed is AFP; the disease is hepatocellular carcinoma.